Marimed Inc
MariMed Inc. engages in cultivation, production, and selling of branded cannabis products in the United States and internationally. The company sells cannabis flower, vapes, and concentrates under the Nature's Heritage brand; cannabis fruit chews that delivers better sleep, pain relief, stress relief, and others under Betty's Eddies brand; and cannabis-infused ice creams under Emack & Bolio's bra… Read more
Marimed Inc (MRMD) - Total Liabilities
Latest total liabilities as of September 2025: $151.28 Million USD
Based on the latest financial reports, Marimed Inc (MRMD) has total liabilities worth $151.28 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Marimed Inc - Total Liabilities Trend (2014–2024)
This chart illustrates how Marimed Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Marimed Inc Competitors by Total Liabilities
The table below lists competitors of Marimed Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Trakcja PRKiI S.A.
WAR:TRK
|
Poland | zł1.26 Billion |
|
Footway Group AB Series B
ST:FOOT-B
|
Sweden | Skr381.00 Million |
|
Kaplamin Ambalaj Sanayi ve Ticaret AS
IS:KAPLM
|
Turkey | TL701.17 Million |
|
Memscap Regpt
PA:MEMS
|
France | €6.71 Million |
|
MFEC PCL
BK:MFEC
|
Thailand | ฿3.58 Billion |
|
Digital Mediatama Maxima PT
JK:DMMX
|
Indonesia | Rp195.58 Billion |
|
Unique Optical Industrial Co Ltd
TWO:3441
|
Taiwan | NT$233.37 Million |
Liability Composition Analysis (2014–2024)
This chart breaks down Marimed Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.69 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.74 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Marimed Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Marimed Inc (2014–2024)
The table below shows the annual total liabilities of Marimed Inc from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $147.11 Million | +16.56% |
| 2023-12-31 | $126.21 Million | +120.77% |
| 2022-12-31 | $57.17 Million | +16.24% |
| 2021-12-31 | $49.18 Million | -8.28% |
| 2020-12-31 | $53.62 Million | -2.94% |
| 2019-12-31 | $55.24 Million | +160.63% |
| 2018-12-31 | $21.20 Million | +0.01% |
| 2017-12-31 | $21.19 Million | +132.54% |
| 2016-12-31 | $9.11 Million | +59.80% |
| 2015-12-31 | $5.70 Million | +70.89% |
| 2014-12-31 | $3.34 Million | -- |